Next Article in Journal
Enhancing Clinical Pharmacy Specialist Involvement in Transitions of Care Focusing on Ambulatory Care Sensitive Conditions within a Veterans Affairs Healthcare System
Next Article in Special Issue
Pharmacists’ Role in Managing Patients with Chronic Lymphocytic Leukemia
Previous Article in Journal
Substandard and Falsified Medicines in Myanmar
Previous Article in Special Issue
Oncology Pharmacists Can Reduce the Projected Shortfall in Cancer Patient Visits: Projections for Years 2020 to 2025
Open AccessArticle

Evaluation of a Pharmacist Led Oral Chemotherapy Clinic: A Pilot Program in the Gastrointestinal Oncology Clinic at an Academic Medical Center

Health Simon Cancer Center, Indiana University, Indianapolis, IN 46202, USA
*
Author to whom correspondence should be addressed.
Pharmacy 2020, 8(1), 46; https://doi.org/10.3390/pharmacy8010046
Received: 25 February 2020 / Revised: 13 March 2020 / Accepted: 17 March 2020 / Published: 20 March 2020
Oral chemotherapy represents a major patient-centric advancement in therapy convenience. However, ownership of safe and correct administration of these agents requires significant patient education. To address this challenge, an in-person pharmacist-led oral chemotherapy education clinic in gastrointestinal oncology patients within an academic medical center was created and assessed. In this pilot program, a medication-specific quiz was administered to patients before and after education performed by a pharmacist to assess patient understanding of their new oral chemotherapy. A five-question satisfaction survey was also administered at the conclusion of the pharmacist clinic visit. Primary outcome was the percentage difference between pre-and post-education quiz scores. Secondary outcomes included patient satisfaction, time to treatment initiation, and number of pharmacist interventions. Frequencies and medians were used to describe categorical and continuous variables, respectively. Of the 18 patients analyzed, 50% were male and median age was 59.5 years. Approximately 28% had colon cancer, and 61% were treated with capecitabine. The median post-education scores improved from a pre-education score of 75% to 100%. Overall, seventeen of the eighteen patients responded with “strongly agree” to all satisfaction survey statements. An in-person oncology pharmacist-led oral chemotherapy education session demonstrated an improvement in patients’ understanding of their new oral chemotherapy treatment. View Full-Text
Keywords: oral chemotherapy; oral oncolytic; oncology pharmacy; education; patient satisfaction; gastrointestinal oncology; specialty pharmacy oral chemotherapy; oral oncolytic; oncology pharmacy; education; patient satisfaction; gastrointestinal oncology; specialty pharmacy
Show Figures

Figure 1

MDPI and ACS Style

Darling, J.O.; Raheem, F.; Carter, K.C.; Ledbetter, E.; Lowe, J.F.; Lowe, C. Evaluation of a Pharmacist Led Oral Chemotherapy Clinic: A Pilot Program in the Gastrointestinal Oncology Clinic at an Academic Medical Center. Pharmacy 2020, 8, 46.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop